|Articles|March 1, 2013
- Pharmaceutical Executive-03-01-2013
- Volume 0
- Issue 0
PE, March 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Less Selling, More Timeabout 13 years ago
Test and Learn: Making Confident Decisions on the Commercial Sideabout 13 years ago
Specialty Service Programs: Gearing up for Next Generation Technologiesabout 13 years ago
China and the Emerging Markets Challengeabout 13 years ago
Embedding Market Access in Today's Pharma Business Modelabout 13 years ago
Who's Really in Charge of European Drug Registration?about 13 years ago
Brand of the Year: Januviaabout 13 years ago
Early Engagement with Medical Laboratoriesabout 13 years ago
Pharma in the News: Pharm Exec's Annual Press Auditabout 13 years ago
Safeguarding the Value of Patent AssetsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
5